Social Neuroscience Lab, Max Planck Society, Berlin, Germany.
Charité - Universitätsmedizin, Corporate Member of the Free University of Berlin and Humboldt University of Berlin, Institute for Medical Psychology, Berlin, Germany.
PLoS One. 2021 Nov 4;16(11):e0256323. doi: 10.1371/journal.pone.0256323. eCollection 2021.
The SARS-CoV-2 pandemic has led to a mental health crisis on a global scale. Epidemiological studies have reported a drastic increase in mental health problems, such as depression and anxiety, increased loneliness and feelings of disconnectedness from others, while resilience levels have been negatively affected, indicating an urgent need for intervention. The current study is embedded within the larger CovSocial project which sought to evaluate longitudinal changes in vulnerability, resilience and social cohesion during the pandemic. The current second phase will investigate the efficacy of brief online mental training interventions in reducing mental health problems, and enhancing psychological resilience and social capacities. It further provides a unique opportunity for the prediction of intervention effects by individual biopsychosocial characteristics and preceding longitudinal change patterns during the pandemic in 2020/21.
We will examine the differential effects of a socio-emotional (including 'Affect Dyad') and a mindfulness-based (including 'Breathing Meditation') intervention, delivered through a web- and cellphone application. Participants will undergo 10 weeks of intervention, and will be compared to a retest control group. The effectiveness of the interventions will be evaluated in a community sample (N = 300), which is recruited from the original longitudinal CovSocial sample. The pre- to post-intervention changes, potential underlying mechanisms, and prediction thereof, will be assessed on a wide range of outcomes: levels of stress, loneliness, depression and anxiety, resilience, prosocial behavior, empathy, compassion, and the impact on neuroendocrine, immunological and epigenetic markers. The multi-method nature of the study will incorporate self-report questionnaires, behavioral tasks, ecological momentary assessment (EMA) approaches, and biological, hormonal and epigenetic markers assessed in saliva.
Results will reveal the differential effectiveness of two brief online interventions in improving mental health outcomes, as well as enhancing social capacities and resilience. The present study will serve as a first step for future application of scalable, low-cost interventions at a broader level to reduce stress and loneliness, improve mental health and build resilience and social capacities in the face of global stressors.
This trial has been registered on May 17, 2020 with the ClinicalTrials.gov NCT04889508 registration number (clinicaltrials.gov/ct2/show/NCT04889508).
SARS-CoV-2 大流行在全球范围内引发了一场心理健康危机。流行病学研究报告称,心理健康问题(如抑郁和焦虑)急剧增加,孤独感和与他人脱节感增强,而适应力水平受到负面影响,表明急需干预。本研究嵌入在更大的 CovSocial 项目中,该项目旨在评估大流行期间脆弱性、适应力和社会凝聚力的纵向变化。目前的第二阶段将研究简短的在线心理训练干预在减少心理健康问题、增强心理适应力和社会能力方面的效果。它还为通过个体的生物心理社会特征和 2020/21 年大流行期间的先前纵向变化模式预测干预效果提供了独特的机会。
我们将研究社会情感(包括“情感对偶”)和基于正念的(包括“呼吸冥想”)干预的差异效果,通过网络和手机应用程序进行干预。参与者将接受 10 周的干预,并与重新测试的对照组进行比较。将在社区样本(N=300)中评估干预的有效性,该样本是从原始的 CovSocial 纵向样本中招募的。将评估广泛的结果,包括压力、孤独感、抑郁和焦虑水平、适应力、亲社会行为、同理心、同情心以及对神经内分泌、免疫和表观遗传标志物的影响,以评估干预前后的变化、潜在机制及其预测。该研究的多方法性质将包括自我报告问卷、行为任务、生态瞬时评估(EMA)方法以及唾液中评估的生物、激素和表观遗传标志物。
结果将揭示两种简短在线干预在改善心理健康结果、增强社会能力和适应力方面的差异效果。本研究将作为未来在更广泛层面上应用可扩展、低成本干预措施的第一步,以减少压力和孤独感、改善心理健康并建立适应力和社会能力,以应对全球压力源。
该试验于 2020 年 5 月 17 日在 ClinicalTrials.gov 上注册,注册号为 NCT04889508(clinicaltrials.gov/ct2/show/NCT04889508)。